Cellebrite DI CLBT

What the company does

Cellebrite DI is a mid-cap company in the Technology sector (Software - Infrastructure), with a market value of $2.8B, based in the USA.

It employs about 1,285 people and has been listed since Aug 31, 2021.

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency.

Cheap or expensive? priced in line with its group

Its price-to-earnings (P/E) is 49.0 versus 43.5 for the median of the Technology sector in our universe (65 companies) — priced in line with its group.

Revenue is growing 16% versus the same quarter last year.

On analysts' next-year forecasts the multiple drops to 35.7 — they expect higher earnings.

The average analyst price target is 15.36, 36% above the current price (their view, not ours).

The stock sits at 16% of its one-year range (0% = the low, 100% = the high).

The risks

• • The stock is 44% below its one-year high.

Strengths

• ✅ Profitable — 5 of every 100 dollars of revenue stays as profit.
• ✅ Generates free cash flow — profit becomes cash in the bank.
• ✅ More cash than debt.
• ✅ Most analysts rate it buy (8 vs 0).
• ✅ Revenue is growing 16% a year.

What changed this week

Over the past week the stock rose 1.7% (for comparison: S&P 500 +1.2%, sector ETF XLK -0.5%).

No notable news about the company was found in the past week.

What changed since last week

This is the first summary for this stock; from next week this section shows what changed.